Latest News & Updates
Other trending news you may like to read
Greenwich LifeSciences Reports Promising Phase III Data For FLAMINGO-01 Trial Evaluating GLSI-100, Showing Significant Drop In Breast Cancer Recurrence Rates
Greenwich LifeSciences reports Phase III FLAMINGO-01 data showing GLSI-100 achieves 0.7% annual recurrence rate in breast cancer, an 83% reduction versus 4% historical control.
Vaibhavi M.
ImmunityBio’s ANKTIVA Plus BCG Added To NCCN 2026 Guidelines For Broader Bladder Cancer Use
NCCN updates 2026 bladder cancer guidelines to include ANKTIVA plus BCG for BCG-unresponsive papillary-only NMIBC, expanding recommendations beyond CIS patients.
Vaibhavi M.
Neuronetics Appoints Medtech Veteran Dan Reuvers As Chief Executive Officer, Succeeding Keith Sullivan
Neuronetics appoints medtech veteran Dan Reuvers as President and CEO effective March 23, 2026, succeeding Keith Sullivan who retires after five years leading the company.
Vaibhavi M.
HCW Biologics Secures $7M Upfront License Payment From Beijing Trimmune Biotech, Advanced China Licensing Deal For HCW11-006
HCW Biologics receives $7M upfront from Beijing Trimmune Biotech to license HCW11-006 in China, retaining reacquisition rights post Phase 1 and royalties on future sales.
Vaibhavi M.
